Skip to main content

Table 3 Odds ratio of developing HSP associated with vaccines

From: Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control study

Vaccine Cases (288) Controlsa (617) Crude OR (95 % CI) Adjusted ORb (95 % CI)
MMR 8 (2.8 %) 6 (1 %) 2.7 (0.8–9.7) 3.4 (1.2–10.0)
DTaP 4 (1.4) 6 (1 %) 1.4 (0.3–6.1) 2.0 (0.5–7.7)
Any vaccine 21 (7.3 %) 68 (11 %) 0.6 (0.4–1.1) 0.9 (0.5–1.4)
  1. agastroduodenal lesions bOR adjusted by age